Colorectal Cancer Prevention in High Risk Populations

Chicago, IL US
January 28, 2017
This unique program will provide state-of-the-art approaches to diagnosis and management of colorectal cancer in high risk populations. Patients with inflammatory bowel disease (IBD) are at high risk of developing colon cancer. There has also been an alarming trend of younger individuals developing rectal cancers. Chromoendoscopy provides a new tool for detection of cancer in high risk populations. New endoscopic and surgical approaches are changing diagnosis and management of colorectal cancer. These timely topics grounded in the most recent scientific and clinical guidelines will be covered by leading experts. In addition, case discussions with a multidisciplinary panel of gastroenterologists, surgeons, genetic counselors and pathologists will enable direct application of new knowledge to real-world scenarios. The goal is to provide attendees with tools to improve early identification and prevention of colorectal cancer in high-risk populations.

Target Audience

This activity has been designed for physicians and other health professionals in the specialty of gastroenterology and others interested in the treatment of colorectal cancer and IBD.

Learning Objectives

At the conclusion of this course, the participants should be able to:

  • Discuss the benefits and limitations of chromoendoscopy for patients with inflammatory bowel disease;
  • Describe the technical aspects of performing chromoendoscopy including endoscopic technique and equipment usage;
  • Recognize the clinical knowledge needed to identify patients who should be referred for genetic testing for hereditary colon cancer syndromes;
  • Define surveillance guidelines for neoplasia in IBD as written in the SCENIC Consensus Statement;
  • Describe specifically the endoscopic and surgical management of rectal cancer and inflammatory bowel disease-associated neoplasia.



Additional information
ACGME/ABMS Core Competencies: 
Patient Care and Procedural Skills
Medical Knowledge
For more information, please contact:
CME Coordinator Contact Name: 
Amy Majkowski
CME Coordinator Contact Email: 
CME Coordinator Contact Phone: 
(773) 795-7109
Available credit: 
  • 4.25 AMA PRA Category 1 Credit™
  • 4.25 Participation
Event starts: 
01/28/2017 - 8:00am
Event ends: 
01/28/2017 - 4:00pm
Activity opens: 
Activity expires: 
Center For Care and Discovery
5700 S Maryland Avenue
Chicago, IL 60637
United States
  Sonia Kupfer, MD
  Assistant Professor of Medicine
  Director, Gastrointestinal Cancer Risk and Prevention Clinic
  Joel Pekow, MD
  Assistant Professor of Medicine
  Co-Director, DDRCC Translational Core
  Professor of Medicine
  Section Chief, Gastroenterology, Hepatology & Nutrition
  Co-Director, Digestive Diseases Center


The University of Chicago Pritzker School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Credit Designation Statement
The University of Chicago Pritzker School of Medicine designates this live activity for a maximum of 4.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses and other healthcare professionals will receive a Certificate of Participation. For information on the applicability and acceptance of Certificates of Participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME, please consult your professional licensing board.


To register or for additional information, please click this button or download the brochure and agenda below.


Please login or create an account to proceed.